Physician Scientist – Infectious Diseases
The Division of Infectious Diseases in the Department of Internal Medicine is seeking to recruit a full-time physician-scientist at the Assistant or Associate Professor level to join a vibrant team of physicians and scientists dedicated to preventing, understanding and treating infectious diseases. The applicant’s expertise may be in laboratory or clinical research, and should be relevant to cancer. Examples of research expertise include, but are not limited to, development of novel ways to prevent, diagnose, or treat infectious complications in patients with cancer; the role of infections in cancer development and progression; immunotherapy; and microbiome research. Responsibilities include inpatient consultation service, outpatient clinics, as well as teaching and supervision of fellows. Applicants are required to be BC/BE in Infectious Diseases and to be eligible for a NY State Medical License. The search committee will consider clinical and translational research interests, publication record, and commitment to clinical care and teaching. Academic rank and compensation are dependent upon qualifications and years of experience. Faculty will be recommended for a joint appointment at the Jacobs School of Medicine, University at Buffalo. Roswell Park offers a generous fringe benefits package.
Since 1898, Roswell Park Comprehensive Cancer Center has forged an exemplary reputation with the combined strength of its basic/translational research, multidisciplinary oncology teams, educational programs and compassionate staff. A seamless interface of scientific inquiry and clinical application and an aggressive clinical trials program, Roswell Park commits the infrastructure, intellectual capital and necessary resources to convert scientific discoveries into real-world products and applications. A charter member of the NCCN, Roswell Park is the only NCI-designated comprehensive cancer center in Upstate New York.
RPCI’s contributions to reducing the global cancer toll include initiating the world's first chemotherapy program; pioneering the prostate-specific antigen (PSA) test, photodynamic therapy and the combination chemotherapy of leucovorin and 5-FU (the gold standard for colon cancer treatment); developing the RPMI 1640 Culture Media (used in research labs around the world); and collaborating on landmark studies related to the Human Genome Project. Roswell Park initiated one of the nation's first centers dedicated to Early Phase Clinical Trials and drives innovative cancer research in genetics, cell stress and immunotherapy, leading to new personalized treatments.
Over the last decade, Roswell Park has undergone major growth, adding 1,000 new staff, showing a 198% increase in grant revenues and a 300% increase in clinical revenues, initiating one of the nation's first centers dedicated to phase I clinical research studies, and setting itself apart as a leader in surgical robotics, genetics research, vitamin D research, novel immunotherapies, and tumor microenvironment and behavior/prevention studies
Roswell Park is an equal opportunity employer.
Candidates should email their CV and three references to:
Angela K. Gunther, MBA, AASPR
Senior Faculty Recruitment Administrator
Roswell Park Comprehensive Cancer Center